Powered by HealthTechMovers.com
We added 3 stocks to our Healthcare & Biotech Stock Watchlist today because they are receiving Bullish Sentiment from investors and financial bloggers.
In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention. This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.
UnitedHealth, UNH
Summary: UnitedHealth Group, Inc. provides a wide range of health care products and services, such as health maintenance organizations, point of service plans, preferred provider organizations and managed fee-for-service programs. UnitedHealth has the most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. The company has acquired a number of competing healthcare which transformed it from a pure health insurer to a comprehensive healthcare provider. UnitedHealth reports through two segments: UnitedHealthcare and Optum. UnitedHealthcareis divided into UnitedHealthcare Employer & Individual; UnitedHealthcare Medicare & Retirement; UnitedHealthcare Community & State and UnitedHealthcare Global; providing health care benefits globally. Optum is a technology-enabled health services business serving the broad health care marketplace, including those who need care. The segment is divided into OptumHealth, OptumInsight, OptumRx and Optum eliminations.
- Last Price: $482.13
- Price Change: -$5.44, -1.12%
- Yearly Gain: -0.60%
- Market Cap: $463.83B
- P/E Ratio: 22.784
Here are 3rd party ratings for UNH:
- TipRanks.com: Strong Buy
- TradingView.com: Strong Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 27% (183 out of 250)
What is the sentiment on the street regarding UnitedHealth ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Medium
- Insider Signal: Neutral
- Investor Sentiment: Positive
- Hedge Fund signal: Very Positive
If you are interested in UNH or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on UNH before you decide to make any investment.
Click here for chart >>
CVS Health, CVS
Summary: CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
- Last Price: $71.48
- Price Change: $0.97, 1.38%
- Yearly Gain: -24.08%
- Market Cap: $90.69B
- P/E Ratio: 23.3
Here are 3rd party ratings for CVS:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 12% (220 out of 250)
What is the sentiment on the street regarding CVS Health ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Medium
- Insider Signal: Positive
- Investor Sentiment: Very Positive
- Hedge Fund signal: Very Positive
If you are interested in CVS or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on CVS before you decide to make any investment.
Click here for chart >>
Gritstone Oncology, GRTS
Summary: Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars - first, a proprietary machine learning-based platform, Gritstone EDGE(TM), which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient's tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients' TSNA to drive the patient's immune system to attack and destroy tumors.
- Last Price: $2.39
- Price Change: $0.01, 0.42%
- Yearly Gain: 7.28%
- Market Cap: $196.50M
- P/E Ratio: -1.643
Here are 3rd party ratings for GRTS:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 39% (98 out of 250)
What is the sentiment on the street regarding Gritstone Oncology ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Medium
- Insider Signal: Positive
- Investor Sentiment: Very Positive
- Hedge Fund signal: Neutral
If you are interested in GRTS or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on GRTS before you decide to make any investment.
Click here for chart >>
Thanks for reading!
